ArticlePreventive nutrition and food science2026
Structural Characterization of Squid Peptides and Evaluation of Their Antiphotoaging Activity in Nude Mice.
Article in Preventive nutrition and food science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solar exposure is a major cause of skin photoaging, and this damage is known to be alleviated by natural antioxidants. In this study, four novel squid cyclic peptides (SCPs) with potential antiphotoaging activity were isolated via activity-guided fractionation based on their antiphotoaging effects. We found that SCP-1 [cyclic-(His-Val-Trp-Leu)] and a squid peptide extract (SCP-A-6) protected human skin fibroblasts against ultraviolet (UV)B-induced photoaging. This protection was mediated by the inhibition of inflammatory cytokine overexpression, such as interleukin (IL)-6, IL-1β, and tumor necrosis factor (TNF)-α, and suppression of NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation. Moreover, SCP-1 and SCP-A-6 alleviated UV-induced increases in inflammatory cytokines (IL-1β and TNF-α) in nude mouse skin, thereby confirming their anti-inflammatory and anti-photoaging properties. In addition, histological analysis revealed that SCP-1 and SCP-A-6 improved the structural integrity of photoaged skin. Specifically, they prevented epidermal hyperplasia, reduced the activity of matrix metalloproteinases (MMPs), such as MMP-2 and MMP-9, and suppressed NLRP3 inflammasome activation in photoaged dermal tissue. These results suggest that SCPs may serve as beneficial ingredients for the prevention and management of skin photoaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.